2022 American Transplant Congress
Impact of Cyp 3a5 Genotype on Lcp Tacrolimus Dosing and Monitoring in Kidney Transplantation
Med Univ of South Carolina, Charleston, SC
*Purpose: LCP Tacrolimus has a recommended de novo starting dose of 0.14 mg/kg/day in kidney transplantation (KTR). There is limited data on the influence of…2022 American Transplant Congress
Kidney Transplantation Utilizing SARS-CoV-2 Rt-PCR Positive Donor Kidneys with Immediate Post Exposure Casirivimab /Imdevimab Followed by Thymoglobulin Induction
*Purpose: At the beginning of the pandemic, kidneys from SARS-CoV-2 (COVID) RT-PCR positive donors were not utilized for transplantation, due to the risk of viral…2022 American Transplant Congress
Safety and Efficacy at 4 Years in Post-Liver Transplant Patients with Chronic Kidney Disease Receiving Tenofovir Alafenamide (TAF) for HBV Prophylaxis
*Purpose: Recommended antiviral prophylaxis to prevent recurrent HBV infection after liver transplantation includes tenofovir disoproxil fumarate (TDF). However, given risks of bone/renal toxicity associated with…2022 American Transplant Congress
Mitochondrial Dysfunction and Alloimmunity in Chronic Lung Transplant Rejection
*Purpose: Bronchiolitis obliterans syndrome (BOS) remains a major cause of death after lung transplantation. Unfortunately, we lack effective treatments for BOS as the mechanisms by…2022 American Transplant Congress
Functional Status Assessment in Kidney Transplant Candidates and Recipients: A Single-Center Experience
UC Davis Transplant Center, Sacramento, CA
*Purpose: Functional status assessment (FSA) is important to kidney transplant (KT) candidacy evaluation; a low Fried Frailty score (FFS) is associated with poor waitlist and…2022 American Transplant Congress
Managing Medications During a Pandemic: A Mixed-Methods Study of Perception of Adult Kidney Transplant Recipients and Those Waiting for a Kidney Transplant
*Purpose: Patients interact with healthcare providers (HCP) and pharmacists to manage medications. Little is known about the impact of COVID-19 on medication management. The purpose…2022 American Transplant Congress
Safety and Mortality Benefit of Direct Oral Anticoagulants in Kidney Transplant
*Purpose: Direct oral anticoagulants (DOACs) are increasingly used in renal transplant recipients (RTR). We aim to identify bleeding events and all-cause mortality between DOACs and…2022 American Transplant Congress
Impact of Sub-therapeutic Tacrolimus Troughs at Discharge from Index Admission on Short-Term Outcomes in Kidney Transplant Recipients Receiving Rabbit Anti-Thymocyte Globulin Induction
*Purpose: Kidney transplant (KTx) recipients are often discharged with subtherapeutic tacrolimus (TAC) troughs due to short hospital lengths of stay (LOS) for index KTx admissions.…2022 American Transplant Congress
Racial Differences in the Predictability of Donor-Derived Cell-Free DNA Among Renal Transplant Recipients
1Rush University Medical Center, Chicago, IL, 2CareDx, Brisbane, CA
*Purpose: Donor-Derived Cell-Free DNA (dd-cfDNA) is used to monitor for allograft rejection following renal transplantation. Baseline dd-cfDNA is higher in African American (AA) patients compared…2022 American Transplant Congress
Outcomes in Elderly Black Renal Transplant Recipients Receiving Basiliximab Induction and Early Steroid Withdrawal
University of Maryland Medical Center, Baltimore, MD
*Purpose: Black renal transplant recipients (RTR) carry a higher risk of rejection (BPAR) and graft loss due to immunologic and non-immunologic factors. Lymphocyte depleting induction…
- « Previous Page
- 1
- 2
- 3
- 4
- 5
- …
- 190
- Next Page »